NASDAQ:QURE

Uniqure N.v Stock Insider Trading

etoro logo Buy QURE
*Your capital is at risk
$41.10
-1.53 (-3.59%)
At Close: Jul 13, 2026

uniQure N.V Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -78.89. In total, the insiders bought 1.29M and sold 485.14K QURE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-78.89
Buy 1.29M shares
Sell 485.14K shares
56% Buy Activity
Moderate Negative Correlation
Sell Signal High Confidence
Jun 17, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -78.89.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 02, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 21 082
Value: $408.8K
Jul 02, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 9 200
Value: $408.8K
Jul 02, 2026
Buy
Ordinary Shares
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 21 082
Value: $408.8K
Jul 02, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 7 600
Value: $348.8K
Jul 02, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 282
Value: $194.5K
Jun 30, 2026
Sell
Ordinary Shares
S-Sale
Abi-saab Walid
Chief Medical Officer
Officer 10 000
Value: $464.6K
Jun 30, 2026
Sell
Ordinary Shares
S-Sale
Abi-saab Walid
Chief Medical Officer
Officer 20 000
Value: $928.0K
Jun 30, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Abi-saab Walid
Chief Medical Officer
Officer 10 000
Value: $55.9K
Jun 30, 2026
Buy
Ordinary Shares
M-Exempt
Abi-saab Walid
Chief Medical Officer
Officer 10 000
Value: $55.9K
Jun 30, 2026
Sell
Ordinary Shares
S-Sale
Kaye Jack
Director
Director 4 107
Value: $190.9K
Jun 30, 2026
Buy
Ordinary Shares
M-Exempt
Kaye Jack
Director
Director 4 107
Value: $152.0K
Jun 30, 2026
Buy
Ordinary Shares
M-Exempt
Kaye Jack
Director
Director 17 060
Value: $344.3K
Jun 30, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kaye Jack
Director
Director 4 107
Value: $152.0K
Jun 30, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kaye Jack
Director
Director 17 060
Value: $344.3K
Jun 30, 2026
Sell
Ordinary Shares
S-Sale
Kaye Jack
Director
Director 17 060
Value: $792.1K
Jun 26, 2026
Sell
Ordinary Shares
S-Sale
Abi-saab Walid
Chief Medical Officer
Officer 1 434
Value: $67.2K
Jun 25, 2026
Buy
Ordinary Shares
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 28 716
Value: $910.6K
Jun 25, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 28 716
Value: $1.44M
Jun 25, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 28 716
Value: $910.6K
Jun 24, 2026
Buy
Ordinary Shares
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 128
Value: $130.9K
Jun 24, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 6 696
Value: $334.8K
Jun 24, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 128
Value: $130.9K
Jun 18, 2026
Buy
Ordinary Shares
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 656
Value: $147.6K
Jun 18, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 656
Value: $232.8K
Jun 18, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 37 015
Value: $1.85M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT UNIQURE N.V.
uniQure N.V
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE